Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18786053 | METHOD FOR PREDICTING CONSUMPTION OF SURGICAL CONSUMABLES DURING SURGICAL OPERATION | July 2024 | February 2026 | Abandon | 19 | 1 | 0 | No | No |
| 18716788 | Self-Controlling Wearable Device | June 2024 | January 2026 | Abandon | 20 | 1 | 0 | No | No |
| 18562191 | METHOD AND SYSTEM FOR AGGREGATING DATA | November 2023 | February 2026 | Abandon | 27 | 1 | 0 | No | No |
| 18460320 | SYSTEMS AND METHODS FOR GENERATING HISTORY AND PHYSICAL EXAM NOTES | September 2023 | September 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18213542 | FORMULATION INFORMATION MANAGEMENT DEVICE, METHOD, AND COMPUTER-READABLE MEDIUM | June 2023 | March 2026 | Abandon | 32 | 2 | 0 | Yes | No |
| 18205249 | SCALABLE FRAMEWORK FOR DIGITAL MESH | June 2023 | March 2026 | Abandon | 33 | 2 | 0 | No | No |
| 18311487 | Treatment Support | May 2023 | March 2026 | Abandon | 34 | 2 | 0 | No | No |
| 18024748 | INFORMATION PROCESSING DEVICE, SUBJECT TERMINAL, INFORMATION PROCESSING SYSTEM, AND METHOD FOR CONTROLLING INFORMATION PROCESSING SYSTEM | March 2023 | May 2025 | Abandon | 26 | 1 | 0 | No | No |
| 18020921 | METHOD FOR GENERATING INDIVIDUAL NUTRITIONAL RECOMMENDATIONS FOR A USER | February 2023 | March 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18105617 | METHOD FOR PRESCRIBING A CLINICAL TRIAL | February 2023 | December 2025 | Abandon | 34 | 2 | 0 | No | No |
| 18159810 | MEDICAL PROCEDURE COST COMPARISON TOOL | January 2023 | May 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18149159 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | January 2023 | September 2025 | Abandon | 33 | 2 | 0 | Yes | No |
| 18062020 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | December 2022 | August 2025 | Abandon | 32 | 2 | 0 | No | No |
| 18061922 | SYSTEMS AND METHODS FOR PROCESSING MEDICAL DATA | December 2022 | April 2025 | Abandon | 28 | 1 | 0 | No | No |
| 17967863 | ARTIFICIAL INTELLIGENCE/MACHINE LEARNING BASED BIOINFORMATICS PLATFORM FOR ENCEPHALOPATHY AND MEDICAL DECISION IMPROVEMENT METHOD | October 2022 | September 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17914723 | DISCOMFORT GRAPH GENERATING METHOD AND SYSTEM | September 2022 | March 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17900815 | Synchronous Clinical Data Collection, Analysis and Reporting System and Method Therefor | August 2022 | February 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17879839 | METHODS AND SYSTEMS FOR PREDICTING AND PREVENTING FREQUENT PATIENT READMISSION | August 2022 | January 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17879806 | METHODS AND SYSTEMS FOR DETERMINING AND DISPLAYING PATIENT READMISSION RISK | August 2022 | January 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17816878 | PLATFORM FOR ROUTING CLINICAL DATA | August 2022 | August 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17768111 | System and Method for Steering Care Plan Actions by Detecting Tone, Emotion, and/or Health Outcome | April 2022 | October 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17657373 | HEARING DEVICE WITH HEALTH FUNCTION | March 2022 | March 2025 | Abandon | 35 | 2 | 0 | Yes | No |
| 17657376 | SYSTEMS AND METHODS FOR GENERATING TARGETED OUTPUTS | March 2022 | October 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17701231 | SYSTEM AND METHODS OF MONITORING A PATIENT AND DOCUMENTING TREATMENT | March 2022 | May 2025 | Abandon | 38 | 2 | 0 | No | No |
| 17697216 | APPARATUSES AND METHODS FOR ADAPTIVELY CONTROLLING CRYOABLATION SYSTEMS | March 2022 | May 2025 | Allow | 38 | 3 | 0 | Yes | No |
| 17672820 | ULTRASOUND DIAGNOSTIC APPARATUS AND ULTRASOUND EXAMINATION ASSISTING METHOD | February 2022 | January 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17567113 | CENTRAL MONITORING SYSTEM, MONITORING DEVICE, MOBILE TERMINAL, AND PATIENT MONITORING METHOD | January 2022 | January 2026 | Abandon | 49 | 4 | 0 | Yes | No |
| 17534262 | APPARATUS AND METHOD FOR CALCULATING AN OPTIMUM MEDICATION DOSE | November 2021 | September 2025 | Allow | 46 | 3 | 0 | Yes | No |
| 17521421 | METHODS, SYSTEMS, APPARATUSES, AND DEVICES FOR MANAGING A SPREAD OF INFECTIOUS DISEASES AMONG USERS | November 2021 | December 2024 | Abandon | 37 | 2 | 0 | No | No |
| 17518464 | Communication System and Method | November 2021 | October 2025 | Abandon | 47 | 4 | 0 | Yes | No |
| 17501119 | PREDICTING PERFORMANCE OF CLINICAL TRIAL FACILITATORS USING PATIENT CLAIMS AND HISTORICAL DATA | October 2021 | February 2026 | Abandon | 52 | 4 | 0 | Yes | No |
| 17433212 | SYSTEM AND METHOD FOR DETERMINING QUANTITATIVE HEALTH-RELATED PERFORMANCE STATUS OF A PATIENT | August 2021 | January 2025 | Abandon | 41 | 2 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner EVANS, ASHLEY ELIZABETH works in Art Unit 3687 and has examined 5 patent applications in our dataset. With an allowance rate of 20.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner EVANS, ASHLEY ELIZABETH's allowance rate of 20.0% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by EVANS, ASHLEY ELIZABETH receive 3.00 office actions before reaching final disposition. This places the examiner in the 87% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by EVANS, ASHLEY ELIZABETH is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +25.0% benefit to allowance rate for applications examined by EVANS, ASHLEY ELIZABETH. This interview benefit is in the 72% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 16.7% of applications are subsequently allowed. This success rate is in the 14% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.